LensAR, a provider of laser and advanced 3D imaging technology for refractive cataract surgery, has received the US Food and Drug Administration (FDA) 510(k) clearance for its LensAR Laser System for anterior capsulotomy and lens fragmentation during cataract surgery.
The LensAR Laser System has been developed to meet the advancing needs of refractive cataract surgeons and their patients.
The proprietary 3D-CSI (Confocal Structured Illumination) imaging and biometry system is being designed to image and analyze the anatomy across all grades of cataract to improve proficiency.
Unlike traditional imaging systems, 3D-CSI provides clean, low noise images that are both high contrast and high-resolution from the anterior surface of the cornea to the posterior capsule.
LensAR said the precision of the laser system creates an exact capsulotomy incision size and placement based on IOL selection and fragments high grade cataracts for easier removal.